Literature DB >> 16442911

Cardiac pacemaker: in vitro assessment at 1.5 T.

Frank G Shellock1, David S Fieno, Louise J Thomson, Thomas M Talavage, Daniel S Berman.   

Abstract

BACKGROUND: In vitro testing is used to determine safe parameters before performing magnetic resonance imaging (MRI) on a patient with an implant. Therefore, the objective of this study was to evaluate a cardiac pacemaker using a 1.5-T magnetic resonance (MR) system.
METHODS: A modern cardiac pacemaker (INSIGNIA I PLUS, Model 1298, and FINELINE II, Model 4471, pacing leads; Guidant Corporation, St Paul, MN) was evaluated for magnetic field interactions at 1.5 T. Magnetic resonance imaging-related heating was assessed using 3 different 1.5-T scanners operating at various levels of radio-frequency power and imaging conditions. Functional aspects of the pacemaker were evaluated immediately before and after MRI (9 different pulse sequences). Artifacts were also characterized.
RESULTS: Magnetic field interactions for the pacemaker were minor. Temperature changes measured in vitro were at levels that are not expected to pose a risk for specific MR conditions (< 4.0 degrees C). The function of the pacemaker was unaffected by MRI. Artifacts were minor for the leads and relatively large for the implantable pulse generator.
CONCLUSION: The findings indicated that this pacemaker exhibited acceptable safety features relative to the use of a 1.5-T MR system. If induced currents do not occur for this device, it may be safe for a patient to undergo MRI by following specific conditions. The results are specific to the pacemaker tested, the MR systems, and conditions used in this evaluation.

Entities:  

Mesh:

Year:  2006        PMID: 16442911     DOI: 10.1016/j.ahj.2005.04.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).

Authors:  Peter Thomas Burke; Hamid Ghanbari; Patrick B Alexander; Michael K Shaw; Marcos Daccarett; Christian Machado
Journal:  J Interv Card Electrophysiol       Date:  2010-01-29       Impact factor: 1.900

Review 2.  Dental implant systems.

Authors:  Yoshiki Oshida; Elif B Tuna; Oya Aktören; Koray Gençay
Journal:  Int J Mol Sci       Date:  2010-04-12       Impact factor: 5.923

Review 3.  Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs.

Authors:  Jerold S Shinbane; Patrick M Colletti; Frank G Shellock
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-27       Impact factor: 5.364

4.  Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers.

Authors:  Olaf M Muehling; Reza Wakili; Martin Greif; Franz von Ziegler; Dominik Morhard; Hartmut Brueckmann; Alexander Becker
Journal:  J Cardiovasc Magn Reson       Date:  2014-06-05       Impact factor: 5.364

Review 5.  Imaging techniques in cardiac resynchronization therapy.

Authors:  Maria Isabel Sá; Albert de Roos; Jos J M Westenberg; Lucia J M Kroft
Journal:  Int J Cardiovasc Imaging       Date:  2007-05-15       Impact factor: 2.357

6.  Ventricular assist device implant (AB 5000) prototype cannula: in vitro assessment of MRI issues at 3-Tesla.

Authors:  Frank G Shellock; Samuel Valencerina
Journal:  J Cardiovasc Magn Reson       Date:  2008-05-21       Impact factor: 5.364

7.  Issues with radiofrequency heating in MRI.

Authors:  Jihong Wang
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.